Christian G. Giske

About me
Publications
Grants
CV
Public outreach and news

About me

Professor of Clinical Bacteriology at the Department of Laboratory Medicine

Christian Giske was born in 1975 in Ålesund, Norway. He did his medical training at the Norwegian University of Science and Technology in Trondheim, graduating in 2000. In 2002 he completed his military service as an officer and physician in the Norwegian navy. He has been working at the Karolinska University Laboratory at Karolinska University Hospital since 2002, where he is currently a senior consultant in clinical bacteriology.

Giske became a specialist of clinical microbiology in 2007 and earned his PhD at Karolinska Institutet that same year with a dissertation on the antibiotic resistance of the bacterium Pseudomonas aeruginosa. He became an associate professor in 2010. Christian Giske was appointed Professor of Clinical Bacteriology at Karolinska Institutet on 1 June 2018.

Selected publications

Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2024;64(3):107256
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability
Tellapragada C; Razavi M; Peris PS; Jonsson P; Vondracek M; Giske CG
Article: THE LANCET MICROBE. 2024;5(4):e355-e365
Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial
Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024;79(3):531-538
Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing Enterobacterales: a prospective multicentre study
Montelin H; Camporeale A; Hallgren A; Angelin M; Hogvall J; Balkhed AO; Vading M; Giske CG; Tangden T
Article: MICROBIOLOGY SPECTRUM. 2024;12(2):e0403622-e04022
Molecular characteristics, fitness, and virulence of high-risk and non-high-risk clones of carbapenemase-producing Klebsiella pneumoniae
Ormala-Tiznado A-M; Allander L; Maatallah M; Kabir MH; Brisse S; Sandegren L; Patpatia S; Coorens M; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023;78(12):2895-2901
Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?
Smekal A-K; Furebring M; Lipcsey M; Giske CG
Article: CLINICAL INFECTIOUS DISEASES. 2023;76(3):469-478
Association Between Time to Appropriate Antimicrobial Treatment and 30-day Mortality in Patients With Bloodstream Infections: A Retrospective Cohort Study
Van Heuverswyn J; Valik JK; van der Werff SD; Hedberg P; Giske C; Naucler P
Article: INFECTIOUS DISEASES AND THERAPY. 2022;11(4):1505-1519
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; Macgowan A; Grier S; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; de Cueto M; Oliver A; de Gopegui ER; Cano A; Machuca I; Gozalo-Marguello M; Martinez-Martinez L; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: THE LANCET INFECTIOUS DISEASES. 2022;22(3):390-400
The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden
Edlund C; Ternhag A; Stahlgren GS; Edquist P; Balkhed AO; Athlin S; Mansson E; Tempe M; Bergstrom J; Giske CG; Hanberger H
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(8):2172-2181
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; MacGowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: JAC-ANTIMICROBIAL RESISTANCE. 2021;3(1):dlab001
High prevalence of bla_CTX-M-15 and nosocomial transmission of hypervirulent epidemic clones of Klebsiella pneumoniae at a tertiary hospital in Ethiopia
Sewunet T; Asrat D; Woldeamanuel Y; Ny S; Westerlund F; Aseffa A; Giske CG

Articles

Journal article: THE LANCET MICROBE. 2024;:100902
WHO global research priorities for antimicrobial resistance in human health.
Bertagnolio S; Dobreva Z; Centner CM; Olaru ID; Donà D; Burzo S; Huttner BD; Chaillon A; Gebreselassie N; Wi T; Hasso-Agopsowicz M; Allegranzi B; Sati H; Ivanovska V; Kothari KU; Balkhy HH; Cassini A; Hamers RL; Weezenbeek KV; WHO Research Agenda for AMR in Human Health Collab
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2024;43(5):959-968
A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives
Oldendorff F; Nordberg V; Giske CG; Naver L
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2024;30(4):469-480
Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group
Oliver A; Rojo-Molinero E; Arca-Suarez J; Besli Y; Bogaerts P; Canton R; Cimen C; Croughs PD; Denis O; Giske CG; Graells T; Huang T-DD; Iorga BI; Karatuna O; Kocsis B; Kronenberg A; Lopez-Causape C; Malhotra-Kumar S; Martinez LM; Mazzariol A; Meyer S; Naas T; Notermans DW; Oteo-Iglesias J; Pedersen T; Pirs M; Poeta P; Poirel L; Pournaras S; Sundsfjord A; Szabo D; Tambic-Andrasevic A; Vatcheva-Dobrevska R; Vitkauskiene A; Jeannot K
Article: JAC-ANTIMICROBIAL RESISTANCE. 2024;6(2):dlae039
Quality, availability and suitability of antimicrobial stewardship guidance: a multinational qualitative study
Linde-Ozola Z; Classen AY; Giske CG; Goepel S; Eliakim-Raz N; Semret M; Simonsen GS; Vehreschild JJ; Jorgensen SB; Kessel J; Kleppe LKS; Oma DH; Vehreschild MJGT; Vilde A; Dumpis U
Article: APMIS. 2024;132(2):94-99
Antimicrobial susceptibilities and genomic characteristics of methicillin-resistant Staphylococcus aureus resistant to mupirocin in Stockholm, Sweden
Vestberg N; Razavi M; Giske CG; Fang H
Article: APMIS. 2023;131(10):543-551
Performance of automated antimicrobial susceptibility testing for the detection of antimicrobial resistance in gram-negative bacteria: a NordicAST study
Leegaard TS; Justesen U; Matuschek EG; Giske C; NordicAST SGAAST
Article: JOURNAL OF CONTROLLED RELEASE. 2023;361:260-269
Therapeutic-oligonucleotides activated by nucleases (TOUCAN): A nanocarrier system for the specific delivery of clinical nucleoside analogues
Borsa BA; Hernandez LI; Jimenez T; Tellapragada C; Giske CG; Hernandez FJ
Article: INFECTION. 2023;51(4):1003-1012
Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study
Atamna A; Margalit I; Ayada G; Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; Macgowan A; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; de Cueto M; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez-Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstei Y; Yahav D
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2023;42(8):1001-1009
Recurrent bacteremia with Enterococcus faecalis, the clinical findings predicting endocarditis, and genomic characterization of the isolates: a retrospective cohort study
Tellapragada C; Ostlund H; Giske C; Rasmussen M; Berge A
Article: ANAEROBE. 2023;81:102743
Antimicrobial susceptibility testing of Bacteroides species by disk diffusion: The NordicAST Bacteroides study
Stubhaug TT; Giske CG; Justesen US; Kahlmeter G; Matuschek E; Sundsfjord A; Skaare D
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2023;29(6):758-764
Towards clinical breakpoints for non-tuberculous mycobacteria-Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution
Froberg G; Maurer FP; Chryssanthou E; Fernstrom L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyrylainen H-L; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schon T
Article: COMMUNICATIONS MEDICINE. 2023;3(1):31
Strain-level bacterial typing directly from patient samples using optical DNA mapping
Nyblom M; Johnning A; Frykholm K; Wrande M; Mueller V; Goyal G; Robertsson M; Dvirnas A; Sewunet T; Sriram KK; Ambjornsson T; Giske CG; Sandegren L; Kristiansson E; Westerlund F
Article: ELIFE. 2023;12:e82785
Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
Mikaeloff F; Gelpi M; Benfeitas R; Knudsen AD; Vestad B; Hogh J; Hov JR; Benfield T; Murray D; Giske CG; Mardinoglu A; Troseid M; Nielsen SD; Neogi U; Hens N
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2023;41(1):91-97
Agreement between rapid antigen detection test and culture for group A streptococcus in patients recently treated for pharyngotonsillitis-a prospective observational study in primary care
Rystedt K; Hedin K; Tyrstrup M; Skoog-Stahlgren G; Edlund C; Giske CG; Gunnarsson R; Sundvall P-D
Article: JAC-ANTIMICROBIAL RESISTANCE. 2022;5(1):dlad006
Effects of penicillin V on the faecal microbiota in patients with pharyngotonsillitis-an observational study
Rystedt K; Edquist P; Giske CG; Hedin K; Tyrstrup M; Stahlgren GS; Sundvall P-D; Edlund C
Article: JAC-ANTIMICROBIAL RESISTANCE. 2022;5(1):dlad004
Identification and characterization of plasmids carrying the mobile colistin resistance gene mcr-1 using optical DNA mapping
Sriram K; Wranne MS; Sewunet T; Ekedahl E; Coorens M; Tangkoskul T; Thamlikitkul V; Giske CG; Westerlund F
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2022;9(Supplement_2):ofac492.595
542. Nanopore and Illumina sequencing for pathogen metagenomics and host transcriptomics of cerebrospinal fluid in infantile central nervous system infections
Horiba K; Torii Y; Yamaguchi M; Haruta K; Okumura T; Suzuki T; Kawano Y; Kawada J-I; Hara S; Giske C; Ogi T; Ito Y
Article: OPEN FORUM INFECTIOUS DISEASES. 2022;9(10):ofac504
Performance of Nanopore and Illumina Metagenomic Sequencing for Pathogen Detection and Transcriptome Analysis in Infantile Central Nervous System Infections
Horiba K; Torii Y; Aizawa Y; Yamaguchi M; Haruta K; Okumura T; Suzuki T; Kawano Y; Kawada J-I; Hara S; Saitoh A; Giske CG; Ogi T; Ito Y
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2022;60(4):106668
Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens
Antonelli A; Coppi M; Tellapragada C; Hasan B; Maruri A; Gijon D; Morecchiato F; de Vogel C; Verbon A; van Wamel W; Kragh KN; Frimodt-Moller N; Canton R; Giske CG; Rossolini GM
Article: MICROORGANISMS. 2022;10(7):1470
Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method
Tscherne A; Mantel E; Boskani T; Budniak S; Elschner M; Fasanella A; Feruglio SL; Galante D; Giske CG; Grunow R; Henczko J; Hinz C; Iwaniak W; Jacob D; Kedrak-Jablonska A; Jensen VK; Johansen TB; Kahlmeter G; Manzulli V; Matuschek E; Melzer F; Nuncio MS; Papaparaskevas J; Pelerito A; Solheim M; Thomann S; Tsakris A; Wahab T; Weiner M; Zoeller L; Zange S
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2022;41(7):1093-1098
Evaluation of a pneumonia multiplex PCR panel for detection of bacterial respiratory tract pathogens from serial specimens collected from hospitalized COVID-19 patients
Tellapragada C; Ydsten KA; Ternhag A; Giske CG
Article: SCIENTIFIC REPORTS. 2022;12(1):9301
A simple cut and stretch assay to detect antimicrobial resistance genes on bacterial plasmids by single-molecule fluorescence microscopy
Goyal G; Ekedahl E; Nyblom M; Krog J; Frobrant E; Brander M; Sewunet T; Tangkoskul T; Giske CG; Sandegren L; Thamlikitkul V; Ambjornsson T; Westerlund F
Article: INFECTION PREVENTION IN PRACTICE. 2022;4(2):100215
Molecular and genetic characterization of emerging carbapenemase-producing Acinetobacter baumannii strains from patients and hospital environments in Bangladesh
Farzana R; Swedberg G; Giske CG; Hasan B
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2022;29:405-412
Polyclonal spread of bla_CTX-M-15 through high-risk clones of Escherichia coli at a tertiary hospital in Ethiopia
Sewunet T; Asrat D; Woldeamanuel Y; Ny S; Westerlund F; Aseffa A; Giske CG
Article: GENE. 2022;822:146355
Comprehensive pan-genomic, resistome and virulome analysis of clinical OXA-48 producing carbapenem-resistant Serratia marcescens strains
Bolourchi N; Goodarzi NNG; Giske CG; Nematzadeh S; Jouriani FH; Solgi H; Badmasti F
Article: CRITICAL CARE MEDICINE. 2022;50(5):825-836
Ventilator-Associated Lower Respiratory Tract Bacterial Infections in COVID-19 Compared With Non-COVID-19 Patients*
Hedberg P; Ternhag A; Giske CG; Stralin K; Ozenci V; Johansson N; Spindler C; Hedlund J; Martensson J; Naucler P
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(5):731.e1-731.e7
Blood culture diagnostics: a Nordic multicentre survey comparison of practices in clinical microbiology laboratories
Akerlund A; Petropoulos A; Malmros K; Tangden T; Giske CG
Article: BIOMEDICINES. 2022;10(5):982
Characterization of the Upper Respiratory Bacterial Microbiome in Critically Ill COVID-19 Patients
Bai X; Narayanan A; Skagerberg M; Cena-Diez R; Giske CG; Stralin K; Sonnerborg A
Article: BMC RESEARCH NOTES. 2022;15(1):113
Evaluation of multi-sample 16S ribosomal DNA sequencing for the diagnosis of postoperative bone and joint infections during antimicrobial treatment
Wallander K; Vondracek M; Giske CG
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2022;28:254-263
Comparative resistome and virulome analysis of clinical NDM-1-producing carbapenem-resistant Enterobacter cloacae complex
Bolourchi N; Giske CG; Nematzadeh S; Mirzaie A; Abhari SS; Solgi H; Badmasti F
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2022;59(2):106496
High diversity of bla_NDM-1-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital
Sriram KK; Ekedahl E; Ngoc TBH; Sewunet T; Berglund B; Lundberg L; Nematzadeh S; Nilsson M; Nilsson LE; Le NK; Dien MT; Hanberger H; Olson L; Larsson M; Giske CG; Westerlund F
Article: FRONTIERS IN MICROBIOLOGY. 2022;13:951857
Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter spp. from clinical samples at Jimma medical center, Ethiopia
Sewunet T; Asrat D; Woldeamanuel Y; Aseffa A; Giske CG
Article: PLOS ONE. 2022;17(10):e0274419
Fecal carriage and clonal dissemination of bla_NDM-1 carrying Klebsiella pneumoniae sequence type 147 at an intensive care unit in Lao PDR
Sewunet T; Sriram KK; Ha HN; Sithivong N; Ngoc TBH; Sychareun V; Nengmongvang K; Larsson M; Olson L; Westerlund F; Giske CG
Article: FRONTIERS IN PEDIATRICS. 2022;10:866762
Case Report: Fatal Outcome for a Preterm Newborn With Meningitis Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 1193
Oldendorff F; Linner A; Finder M; Eisenlauer P; Kjellberg M; Giske CG; Nordberg V
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(1):66-72
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations
Carrara E; Savoldi A; Piddock LJV; Franceschi F; Ellis S; Sharland M; Brink AJ; Harris PNA; Levy-Hara G; Rohit A; Tsioutis C; Zayyad H; Giske C; Chiamenti M; Bragantini D; Righi E; Gorska A; Tacconelli E
Journal article: GENE REPORTS. 2021;25:101394
Genome analysis of an OXA-48-producing carbapenem- and colistin-resistant Klebsiella pneumoniae sequence type 11 clone isolated from an inpatient
Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Solgi H; Badmasti F
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2021;40(12):2479-2485
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
Tellapragada C; Giske CG
Article: EUROSURVEILLANCE. 2021;26(46):2002094
Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018
Gagliotti C; Hogberg LD; Billstrom H; Eckmanns T; Giske CG; Heuer OE; Jarlier V; Kahlmeter G; Wong DLF; Monen J; Murchan S; Simonsen GS; Subelj M; Andrasevic AT; Zabicka D; Zemlickova H; Monnet DL
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021;65(12):e0106521-10.1128/aac.01021
Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases
Olsson A; Hong M; Al-Farsi H; Giske CG; Lagerback P; Tangden T
Article: MICROBIOLOGY SPECTRUM. 2021;9(2):e0144021-e01421
In Vitro Activity of Omadacycline and Five Comparators against Contemporary Ribotypes of Clostridioides difficile in Stockholm, Sweden
Camporeale A; Tellapragada C; Kornijenko J; Nord CE; Giske CG
Article: ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS. 2021;20(1):74
Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiellapneumoniae clinical strains isolated from two Iranian hospitals
Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Goodarzi NN; Solgi H; Badmasti F
Article: MICROMACHINES. 2021;12(10):1234
A Parallelized Nanofluidic Device for High-Throughput Optical DNA Mapping of Bacterial Plasmids
Kk S; Lin Y-L; Sewunet T; Wrande M; Sandegren L; Giske CG; Westerlund F
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2021;40(9):1803-1813
A decade of neonatal sepsis caused by gram-negative bacilli-a retrospective matched cohort study
Nordberg V; Iversen A; Tidell A; Ininbergs K; Giske CG; Naver L
Article: ANTIBIOTICS. 2021;10(9):1029
Optical DNA Mapping of Plasmids Reveals Clonal Spread of Carbapenem-Resistant Klebsiella pneumoniae in a Large Thai Hospital
Kk S; Sewunet T; Wangchinda W; Tangkoskul T; Thamlikitkul V; Giske CG; Westerlund F
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2021;27(8):1172.e1-1172.e5
Revisiting colistin susceptibility testing: will adding calcium to Mueller-Hinton agar improve the detection of colistin resistance?
Matuschek E; Brolund A; Lindsjo OK; Giske CG; Byfors S; Kahlmeter G
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2021;25:119-123
Epidemiological typing of ST80 vancomycin-resistant Enterococcus faecium : core genome multilocus sequence typing versus single nucleotide polymorphism-based typing
Dyrkell F; Giske CG; Fang H
Article: ACS INFECTIOUS DISEASES. 2021;7(5):1104-1115
Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
Ray S; Narayanan A; Giske CG; Neogi U; Sonnerborg A; Nowak P
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2021;65(4):e02029-e02020
Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy
Petersson J; Giske CG; Eliasson E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(4):1001-1009
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening
Kragh KN; Gijon D; Maruri A; Antonelli A; Coppi M; Kolpen M; Crone S; Tellapragada C; Hasan B; Radmer S; de Vogel C; van Wamel W; Verbon A; Giske CG; Rossolini GM; Canton R; Frimodt-Moller N
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2021;180(3):893-898
Acute infection as cause of hospitalization of asylum-seeking children and adolescents in Stockholm, Sweden 2015-2016
Hertting O; Luthander J; Giske CG; Bennet R; Eriksson M
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2021;27(2):288.e1-288.e4
Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis
Schon T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(1):152-159
Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis.
Yang Q; Li X; Jia P; Giske C; Kahlmeter G; Turnidge J; Yu Y; Lv Y; Wang M; Sun Z; Lin J; Li Y; Zheng B; Hu F; Guo Y; Chen Z; Li H; Zhang G; Zhang J; Kang W; Duan S; Wang T; Jing R; Xu Y; Chinese Committee on Antimicrobial Susceptibility
Article: PLOS ONE. 2021;16(7):e0254805
High-risk clones of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from the University Hospital Establishment of Oran, Algeria (2011-2012)
Zemmour A; Dali-Yahia R; Maatallah M; Saidi-Ouahrani N; Rahmani B; Benhamouche N; Al-Farsi HM; Giske CG
Article: JOURNAL OF HOSPITAL INFECTION. 2021;107:12-15
Genomic analysis revealed distinct transmission clusters of vancomycin-resistant Enterococcus faecium ST80 in Stockholm, Sweden
Fang H; Froding I; Ullberg M; Giske CG
Article: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2021;11:599924
Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains
Koskinen K; Penttinen R; Ormala-Odegrip A-M; Giske CG; Ketola T; Jalasvuori M
Article: CLINICAL INFECTIOUS DISEASES. 2020;71(9):e523-e529
Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints
Satlin MJ; Lewis JSII; Weinstein MP; Patel J; Humphries RM; Kahlmeter G; Giske CG; Turnidge J
Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2020;39(12):1069-1074
Trends of Pediatric Bloodstream Infections in Stockholm, Sweden: A 20-year Retrospective Study
Luthander J; Bennet R; Giske CG; Eriksson M; Nilsson A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020;64(12):e01585-e01520
A Cross-Sectional Cohort Study of Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Patients with Traveler's Diarrhea
Ljungquist O; Camporeale A; Nematzadeh S; Giske CG; Resman F; Riesbeck K; Tham J
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(11):1488-1492
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination
Schon T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2020;75(10):2804-2811
Optical maps of plasmids as a proxy for clonal spread of MDR bacteria: a case study of an outbreak in a rural Ethiopian hospital
Lin Y-L; Sewunet T; Sriram KK; Giske CG; Westerlund F
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(10):1413.e1-1413.e7
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study
Tellapragada C; Hasan B; Antonelli A; Maruri A; de Vogel C; Gijon D; Coppi M; Verbon A; van Wamel W; Rossolini GM; Canton R; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(8):1039-1043
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
Turnidge J; Kahlmeter G; Canton R; MacGowan A; Giske CG
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2020;64(8):e02351-e02319
Extended-Spectrum-β-Lactamase- and Plasmid AmpC-Producing Escherichia coli Causing Community-Onset Bloodstream Infection: Association of Bacterial Clones and Virulence Genes with Septic Shock, Source of Infection, and Recurrence
Froding I; Hasan B; Sylvin I; Coorens M; Naucler P; Giske CG
Article: CLINICAL INFECTIOUS DISEASES. 2020;70(11):2270-2280
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective Study
Babich T; Naucler P; Karlsson Valik J; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; Macgowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; De Gopegui ER; Cano A; Machuca I; Gozalo-Marguello M; Martinez Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: ACS INFECTIOUS DISEASES. 2020;6(5):1076-1084
Cultivation-Free Typing of Bacteria Using Optical DNA Mapping
Muller V; Nyblom M; Johnning A; Wrande M; Dvirnas A; Sriram KK; Giske CG; Ambjornsson T; Sandegren L; Kristiansson E; Westerlund F
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2020;55(2):105847
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; MacGowan A; Grier S; Chazan B; Yanovskay A; Ben Ami R; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Maurer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez-Martinez L; Gonzalez-Barbera EM; Gomez Alfaro I; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
Article: EUROSURVEILLANCE. 2020;25(2):39-51
Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
Beeton ML; Zhang X-S; Uldum SA; Bebear C; Dumke R; Gullsby K; Ieven M; Loens K; Nir-Paz R; Pereyre S; Spiller OB; Chalker VJ; Bossuyt N; Lagrou K; Mitis G; Koliou M; Havlickova M; Kyncl J; Emborg H-D; Voldstedlund M; MacKenzie CR; Maltezou HC; Georgakopoulou T; Petridou E; Banou K; Balla E; Connell J; Yandle Z; Moran J; Burns K; Michael-Gayego A; Moses AE; Fenech TM; Anestad G; Blystad H; Vestrheim DF; Froes F; Kese D; Socan M; Cano Portero R; Santos Sanz S; Suarez Rodriguez B; Ternhag A; Giske C; Wisell KT; Marques DP; Reynolds A; McMenamin J
Article: PLOS ONE. 2020;15(10):e0239924
Clinical and molecular characteristics of carbapenem non-susceptibleEscherichia coli: A nationwide survey from Oman
Al-Farsi HM; Camporeale A; Ininbergs K; Al-Azri S; Al-Muharrmi Z; Al-Jardani A; Giske CG
Article: PLOS ONE. 2020;15(11):e0242533
Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19
Yu D; Ininbergs K; Hedman K; Giske CG; Stralin K; Ozenci V
Article: FRONTIERS IN MICROBIOLOGY. 2020;11:936
Molecular Epidemiology of OXA-48 and NDM-1 Producing Enterobacterales Species at a University Hospital in Tehran, Iran, Between 2015 and 2016
Solgi H; Nematzadeh S; Giske CG; Badmasti F; Westerlund F; Lin Y-L; Goyal G; Nikbin VS; Nemati AH; Shahcheraghi F
Article: PLOS ONE. 2020;15(3):e0230501
Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection
Holmbom M; Moller V; Nilsson LE; Giske CG; Rashid M-U; Fredrikson M; Hallgren A; Hanberger H; Balkhed AO
Article: INFECTION AND IMMUNITY. 2019;88(1):e00756-e00719
Klebsiella pneumoniae Expressing VIM-1 Metallo-β-Lactamase Is Resensitized to Cefotaxime via Thiol-Mediated Zinc Chelation
Karadottir H; Coorens M; Liu Z; Wang Y; Agerberth B; Giske CG; Bergman P
Journal article: JOURNAL OF RADIOLOGY NURSING. 2019;38(4):254-260
Surface Contamination of CT and MRI Equipment—A Potential Source for Transmission of Hospital-Acquired Infections
Palmqvist C; Samuelsson A; Fröding I; Giske CG
Article: NATURE MICROBIOLOGY. 2019;4(11):1919-1929
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
David S; Reuter S; Harris SR; Glasner C; Feltwell T; Argimon S; Abudahab K; Goater R; Giani T; Errico G; Aspbury M; Sjunnebo S; Feil EJ; Rossolini GM; Aanensen DM; Grundmann H; Koraqi A; Lacej D; Apfalter P; Hartl R; Glupczynski Y; Huang T-D; Strateva T; Marteva-Proevska Y; Tambic Andrasevic A; Butic I; Pieridou-Bagatzouni D; Maikanti-Charalampous P; Hrabak J; Zemlickova H; Hammerum A; Jakobsen L; Ivanova M; Pavelkovich A; Jalava J; Osterblad M; Dortet L; Vaux S; Kaase M; Gatermann SG; Vatopoulos A; Tryfinopoulou K; Toth A; Janvari L; Boo TW; McGrath E; Carmeli Y; Adler A; Pantosti A; Monaco M; Raka L; Kurti A; Balode A; Saule M; Miciuleviciene J; Mierauskaite A; Perrin-Weniger M; Reichert P; Nestorova N; Debattista S; Mijovic G; Lopicic M; Samuelsen O; Haldorsen B; Zabicka D; Literacka E; Canica M; Manageiro V; Kaftandzieva A; Trajkovska-Dokic E; Damian M; Lixandru B; Jelesic Z; Trudic A; Niks M; Schreterova E; Pirs M; Cerar T; Oteo J; Aracil B; Giske C; Sjostrom K; Gur D; Cakar A; Woodford N; Hopkins K; Wiuff C; Brown DJ
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(11):1408-1414
Risk factors for community-onset bloodstream infection with extended-spectrum β-lactamase-producing Enterobacteriaceae: national population-based case-control study
Isendahl J; Giske CG; Wisell KT; Ternhag A; Naucler P
Article: THE BMJ. 2019;367:l5337
Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study
Stahlgren GS; Tyrstrup M; Edlund C; Giske CG; Molstad S; Norman C; Rystedt K; Sundvall P-D; Hedin K
Article: OPEN FORUM INFECTIOUS DISEASES. 2019;6(10):ofz437
Risk for Endocarditis in Bacteremia With Streptococcus-Like Bacteria: A Retrospective Population-Based Cohort Study
Berge A; Kronberg K; Sunnerhagen T; Nilson BHK; Giske CG; Rasmussen M
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(10):1289.e5-1289.e8
Transmission events and antimicrobial susceptibilities of methicillin-resistant Staphylococcus argenteus in Stockholm
Giske CG; Dyrkell F; Arnellos D; Vestberg N; Panna SH; Froding I; Ullberg M; Fang H
Article: CLINICAL INFECTIOUS DISEASES. 2019;69(8):1394-1402
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades
Forsman LD; Jonsson J; Wagrell C; Werngren J; Mansjo M; Wijkander M; Groenheit R; Hammar U; Giske CG; Schon T; Bruchfeld J
Article: EUROSURVEILLANCE. 2019;24(33):7-16
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016
Jarlier V; Hogberg LD; Heuer OE; Campos J; Eckmanns T; Giske CG; Grundmann H; Johnson AP; Kahlmeter G; Monen J; Pantosti A; Rossolini GM; van de Sande-Bruinsma N; Vatopoulos A; Zabicka D; Zemlickova H; Monnet DL; Simonsen GS; Strauss R; Mertens K; Marteva-Proevska YS; Soprek S; Maikanti-Charalampous P; Jakubu V; Sonksen U; Ivanova M; Maugat S; Jalava J; Noll I; Polemis M; Vegh Z; Kristinsson KG; Murchan S; Balode AO; Miciuleviciene J; Perrin M; Woudt SHS; Gran FW; Hryniewicz W; Canica M; Niculcea AS; Schreterova E; Subelj M; Aracil B; Billstrom H; Anderson E
Article: SCIENTIFIC REPORTS. 2019;9(1):10291
Genome and plasmid diversity of Extended-Spectrum β-Lactamase-producing Escherichia coli ST131-tracking phylogenetic trajectories with Bayesian inference
Ny S; Sandegren L; Salemi M; Giske CG
Article: MBIO. 2019;10(4):e00347-e00319
Optical DNA Mapping Combined with Cas9-Targeted Resistance Gene Identification for Rapid Tracking of Resistance Plasmids in a Neonatal Intensive Care Unit Outbreak
Bikkarolla SK; Nordberg V; Rajer F; Mueller V; Kabir MH; Sriram KK; Dvirnas A; Ambjornsson T; Giske CG; Naver L; Sandegren L; Westerlund F
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2019;53(6):820-829
Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis
Froding I; Valik JK; Bolinder L; Naucler P; Giske CG
Article: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. 2019;17:25-34
Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia
Ny S; Edquist P; Dumpis U; Grondahl-Yli-Hannuksela K; Hermese J; Kling A-M; Klingeberg A; Kozlov R; Kallman O; Lis DO; Pomorska-Wesolowska M; Saule M; Wisell KT; Vuopio J; Palagin I; Rantakokko-Jalava K; Laine M; Wuorela M; Marttila J; Eckmanns T; Abu Sin M; Velasco E; Willrich N; Feig M; Noll I; Oberdorfer K; Krenz-Weinreich A; Emrich D; Zill E; Kalka-Moll W; Wichmann O; Ivanchik N; Dyar O; Giske C; Brewczynski PZ; Horon L
Article: EUROSURVEILLANCE. 2019;24(20):6-12
Lyme neuroborreliosis epidemiology in Sweden 2010 to 2014: clinical microbiology laboratories are a better data source than the hospital discharge diagnosis register
Dahl V; Wisell KT; Giske CG; Tegnell A; Wallensten A
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2019;63(4):e02201-e02218
Dynamics of Resistance Plasmids in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae during Postinfection Colonization
Brolund A; Rajer F; Giske CG; Melefors O; Titelman E; Sandegren L
Article: CLINICAL INFECTIOUS DISEASES. 2019;68(4):641-649
Temporal Dynamics and Risk Factors for Bloodstream Infection With Extended-spectrum β-Lactamase-producing Bacteria in Previously-colonized Individuals: National Population-based Cohort Study
Isendahl J; Giske CG; Hammar U; Sparen P; Wisell KT; Ternhag A; Naucler P
Article: LAKARTIDNINGEN. 2019;116:FHCX
[A new SIR definition for antimicrobial susceptibility testing].
Giske C; Hanberger H; Kahlmeter G
Article: FRONTIERS IN MICROBIOLOGY. 2019;10:1372
Two FtsH Proteases Contribute to Fitness and Adaptation of Pseudomonas aeruginosa Clone C Strains
Kamal SM; Rybtke ML; Nimtz M; Sperlein S; Giske C; Trcek J; Deschamps J; Briandet R; Dini L; Jaensch L; Tolker-Nielsen T; Lee C; Romling U
Article: FRONTIERS IN MICROBIOLOGY. 2019;10:2632
Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions
Al-Farsi HM; Al-Adwani S; Ahmed S; Vogt C; Ambikan AT; Leber A; Al-Jardani A; Al-Azri S; Al-Muharmi Z; Toprak MS; Giske CG; Bergman P
Journal article: ИНФЕКЦИЯ И ИММУНИТЕТ. 2018;8(4):563-564
MOLECULAR TYPING OF MYCOBACTERIUM KANSASII — A GLOBAL PERSPECTIVE
Bakuła Z; Arias F; Bachiyska E; Borroni E; Cirillo DM; Coulter C; Giske C; Humięcka J; van Ingen J; Ioannidis P; Kranzer K; Kuzmič U; Levina K; Lillebæk T; Mokrousov I; Morimoto K; Nikolayevskyy V; Norman A; Papaventsis D; Peuchant O; Safianowska A; Ulmann V; Vasiliauskiene E; Won-Jung K; Zhuravlev V; Žolnir-Dovč M; Krenke R; Jagielski T
Journal article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2905
Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study.
Haldorsen B; Giske CG; Hansen DS; Orri Helgason K; Kahlmeter G; Löhr IH; Matuschek E; Österblad M; Rantakokko-Jalava K; Wang M; Småbrekke L; Samuelsen Ø; Sundsfjord A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(10):2738-2747
Performance of the EUCAST disc diffusion method and tw MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study
Haldorsen B; Giske CG; Hansen DS; Helgason KO; Kahlmeter G; Lohr IH; Matuschek E; Osterblad M; Rantakokko-Jalava K; Wang M; Smabrekke L; Samuelsen O; Sundsfjord A
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2018;24(9):1004-1009
Neonatal intestinal colonization with extended-spectrum β-lactamase-eproducing Enterobacteriaceae-a 5-year follow-up study
Nordberg V; Jonsson K; Giske CG; Iversen A; Aspevall O; Jonsson B; Camporeale A; Norman M; Naver L
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(6):1517-1524
Molecular epidemiology of NDM-1-and OXA-48-producing Klebsiella pneumoniae in an Iranian hospital: clonal dissemination of ST11 and ST893
Solgi H; Badmasti F; Giske CG; Aghamohammad S; Shahcheraghi F
Article: BMC INFECTIOUS DISEASES. 2018;18(1):233
Infection with high proportion of multidrug-resistant bacteria in conflict-related injuries is associated with poor outcomes and excess resource consumption: a cohort study of Syrian patients treated in Jordan
Alga A; Wong S; Shoaib M; Lundgren K; Giske CG; von Schreeb J; Malmstedt J
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(3):564-568
MIC-based dose adjustment: facts and fables
Mouton JW; Muller AE; Canton R; Giske CG; Kahlmeter G; Turnidge J
Article: THE LANCET INFECTIOUS DISEASES. 2018;18(3):318-327
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E; Carrara E; Savoldi A; Harbarth S; Mendelson M; Monnet DL; Pulcini C; Kahlmeter G; Kluytmans J; Carmeli Y; Ouellette M; Outterson K; Patel J; Cavaleri M; Cox EM; Houchens CR; Grayson ML; Hansen P; Singh N; Theuretzbacher U; Magrini N; WHO Pathogens Priority List Working Group
Article: PLOS ONE. 2018;13(4):e0195258
Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality
Vading M; Naucler P; Kalin M; Giske CG
Article: PLOS ONE. 2018;13(2):e0192782
Introduction of a hydrolysis probe PCR assay for high-throughput screening of methicillin-resistant Staphylococcus aureus with the ability to include or exclude detection of Staphylococcus argenteus
Bogestam K; Vondracek M; Karlsson M; Fang H; Giske CG
Article: PLOS ONE. 2018;13(11):e0205761
USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016
Enstrom J; Froding I; Giske CG; Ininbergs K; Bai X; Sandh G; Tollstrom U-B; Ullberg M; Fang H
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2017;36(11):2127-2135
Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla _NDM-7 and bla _OXA-48
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Article: INFECTION, GENETICS AND EVOLUTION. 2017;55:318-323
Emergence of carbapenem resistant Escherichia coli isolates producing bla_NDM and bla_OXA-48-like carried on IncA/C and IncL/M plasmids at two Iranian university hospitals
Solgi H; Giske CG; Badmasti F; Aghamohammad S; Havaei SA; Sabeti S; Mostafavizadeh K; Shahcheraghi F
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2017;72(4):1094-1102
Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae: inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation
Froeding I; Vondracek M; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2017;72(2):582-588
Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study
Ny S; Lofmark S; Borjesson S; Englund S; Ringman M; Bergstrom J; Naucler P; Giske CG; Byfors S
Article: THE LANCET INFECTIOUS DISEASES. 2017;17(2):153-163
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
Grundmann H; Glasner C; Albiger B; Aanensen DM; Tomlinson CT; Tambic Andrasevic A; Canton R; Carmeli Y; Friedrich AW; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Nordmann P; Poirel L; Rossolini GM; Seifert H; Vatopoulos A; Walsh T; Woodford N; Monnet DL; Apfalter P; Hartl R; Glupczynski Y; Huang T-D; Strateva T; Marteva-Proevska Y; Andrasevic AT; Butic I; Pieridou-Bagatzouni D; Maikanti-Charalampous P; Hrabak J; Zemlickova H; Hammerum A; Jakobsen L; Ivanova M; Pavelkovich A; Jalava J; Osterblad M; Vaux S; Dortet L; Kaase M; Gatermann SG; Vatopoulos A; Tryfinopoulou K; Toth A; Janvari L; Boo TW; McGrath E; Pantosti A; Monaco M; Balode A; Saule M; Miciuleviciene J; Mierauskaite A; Perrin-Weniger M; Reichert P; Nestorova N; Debattista S; Zabicka D; Literacka E; Canica M; Manageiro V; Damian M; Lixandru B; Niks M; Schreterova E; Pirs M; Cerar T; Oteo J; Aracil B; Giske CG; Sjostrom K; Woodford N; Hopkins K; Wiuff C; Brown DJ; Hardarson H; Samuelsen O; Haldorsen B; Koraqi A; Lacej D; Raka L; Kurti A; Mijovic G; Lopicic M; Jelesic Z; Trudic A; Kraftandzieva A; Trajkovska-Dokic E; Gur D; Cakar A; Carmeli Y; Adler A
Journal article: OPEN FORUM INFECTIOUS DISEASES. 2016;3(suppl_1):1100
14-Year Survey in a Swedish County Reveals an Alarming Increase in Bloodstream Infections (BSI). Comorbidity: An Independent Risk Factor for Both BSI and Mortality
Holmbom M; Giske C; Nilsson LE; Hoffmann M; Fredriksson M; Claesson C; Östholm-Balkhed Å; Hanberger H
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(12):3548-3555
Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers
Vading M; Kabir MH; Kalin M; Iversen A; Wiklund S; Naucler P; Giske CG
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2016;60(10):1425-1436
Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients
Petersson J; Giske CG; Eliasson E
Article: BMC INFECTIOUS DISEASES. 2016;16(1):484
A randomized controlled study of 5 and 10 days treatment with phenoxymethylpenicillin for pharyngotonsillitis caused by streptococcus group A - a protocol study
Skoog G; Edlund C; Giske CG; Molstad S; Norman C; Sundvall P-D; Hedin K
Article: INFECTIOUS DISEASES. 2016;48(8):618-625
Etiology of bone and joint infections: a case series of 363 consecutive patients from an orthopaedic infection unit
Wallander K; Jorup-Ronstrom C; Ullberg M; Tornblom I; Ottosson C; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(8):2321-2325
Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time-kill experiments
Lagerback P; Khine WWT; Giske CG; Tangden T
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(5):1213-1216
A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.
Kabir MH; Meunier D; Hopkins KL; Giske CG; Woodford N
Article: ANNALS OF HEMATOLOGY. 2016;95(6):871-879
Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study
Kjellander C; Bjorkholm M; Kallman O; Giske CG; Weibull CE; Love TJ; Landgren O; Kristinsson SY
Article: SCIENTIFIC REPORTS. 2016;6:23532
Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia
Gyarmati P; Kjellander C; Aust C; Song Y; Ohrmalm L; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(2):333-338
Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB
Niward K; Angeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schon T
Article: PLOS ONE. 2016;11(11):e0166527
14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality
Holmbom M; Giske CG; Fredrikson M; Balkhed AO; Claesson C; Nilsson LE; Hoffmann M; Hanberger H
Article: PLOS ONE. 2016;11(7):e0159694
The IRIDICA PCR/Electrospray Ionization-Mass Spectrometry Assay on Bronchoalveolar Lavage for Bacterial Etiology in Mechanically Ventilated Patients with Suspected Pneumonia
Stralin K; Ehn F; Giske CG; Ullberg M; Hedlund J; Petersson J; Spindler C; Ozenci V
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2015;83(4):371-374
Successful international clones of bla_CTX-M-15-producing Klebsiella pneumoniae with coexpression of plasmid-mediated quinolone resistance (PMQR) determinants in Tehran hospitals
Nematzadeh S; Shahcheraghi F; Iversen A; Giske CG
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2015;104(9):933-939
The aetiology of paediatric bloodstream infections changes after pneumococcal vaccination and group B streptococcus prophylaxis
Luthander J; Bennet R; Giske CG; Nilsson A; Eriksson M
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2015;70(8):2177-2181
Reviving old antibiotics
Theuretzbacher U; Van Bambeke F; Canton R; Giske CG; Mouton JW; Nation RL; Paul M; Turnidge JD; Kahlmeter G
Article: PROSTATE. 2015;75(9):947-956
Rapid Increase in Multidrug-Resistant Enteric Bacilli Blood Stream Infection After Prostate Biopsy-A 10-Year Population-Based Cohort Study
Aly M; Dyrdak R; Nordstrom T; Jalal S; Weibull CE; Giske CG; Gronberg H
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2015;43(3):302-308
Knowledge and understanding of antibiotic resistance and the risk of becoming a carrier when travelling abroad: A qualitative study of Swedish travellers
Wiklund S; Fagerberg I; Ortqvist A; Vading M; Giske CG; Broliden K; TAmmelin A
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2015;4 Suppl 1:80-81
Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Article: LAKARTIDNINGEN. 2015;112:C73S
[Response times can be shortened in microbiological diagnosis of sepsis. Better opening hours in laboratories and active advice enables faster therapy].
Åkerlund A; Sundqvist M; Hanberger H; Åhrén C; Serrander L; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2015;21(2):148.e5-148.e7
Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10
Sturegard E; Angeby KA; Werngren J; Jureen P; Kronvall G; Giske CG; Kahlmeter G; Schon T
Article: EUROSURVEILLANCE. 2015;20(2):21008-28
Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe
Brown D; Canton R; Dubreuil L; Gatermann S; Giske C; MacGowan A; Martinez-Martinez L; Mouton J; Skov R; Steinbakk M; Walton C; Heuer O; Struelens MJ; Hogberg LD; Kahlmeter G
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(6):3630-3632
Meropenem-Clavulanic Acid Has High In Vitro Activity against Multidrug-Resistant Mycobacterium tuberculosis
Forsman LD; Giske CG; Bruchfeld J; Schon T; Jureen P; Angeby K
Article: PLOS ONE. 2015;10(8):e0135756
Bacterial Landscape of Bloodstream Infections in Neutropenic Patients via High Throughput Sequencing
Gyarmati P; Kjellander C; Aust C; Kalin M; Ohrmalm L; Giske CG
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2015;45(1):25-32
Surveillance of antimicrobial resistance among Escherichia coli in wastewater in Stockholm during 1 year: does it reflect the resistance trends in the society?
Kwak Y-K; Colque P; Byfors S; Giske CG; Mollby R; Kuhn I
Article: BMC INFECTIOUS DISEASES. 2014;14:3859
Prevalence of community-acquired bacteraemia in Guinea-Bissau: an observational study
Isendahl J; Manjuba C; Rodrigues A; Xu W; Henriques-Normark B; Giske CG; Naucler P
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(12):7557-7559
Intra- and Extracellular Activities of Trimethoprim-Sulfamethoxazole against Susceptible and Multidrug-Resistant Mycobacterium tuberculosis
Forsman LD; Scohn T; Simonsson USH; Bruchfeld J; Larsson M; Jureen P; Sturegard E; Giske CG; Angeby K
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2014;103(8):856-861
Subnormal levels of vitamin D are associated with acute wheeze in young children
Hammar KS; Hedlin G; Konradsen JR; Nordlund B; Kull I; Giske CG; Pedroletti C; Soderhall C; Melen E
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2014;20(8):O508-O515
Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors
Titelman E; Hasan CM; Iversen A; Naucler P; Kais M; Kalin M; Giske CG
Journal article: LAKARTIDNINGEN. 2014;111(24):1050-1051
[New antibiotics with activity against multidrug-resistant enterobacteriaceae. Combination preparations are now being tested clinically].
Petropoulos EA; Hanberger H; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2014;20(6):O344-O352
Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011
Brolund A; Edquist PJ; Makitalo B; Olsson-Liljequist B; Soderblom T; Wisell KT; Giske CG
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2014;52(5):1582-1589
Performance of the EUCAST Disk Diffusion Method, the CLSI Agar Screen Method, and the Vitek 2 Automated Antimicrobial Susceptibility Testing System for Detection of Clinical Isolates of Enterococci with Low- and Medium-Level VanB-Type Vancomycin Resistance: a Multicenter Study
Hegstad K; Giske CG; Haldorsen B; Matuschek E; Schonning K; Leegaard TM; Kahlmeter G; Sundsfjord A
Article: BMC MICROBIOLOGY. 2014;14:89
The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight
Johansson A; Ekelof J; Giske CG; Sundqvist M
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2014;33(3):399-409
Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan
Habeeb MA; Haque A; Iversen A; Giske CG
Article: LAKARTIDNINGEN. 2014;111(7):268-269
[Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides].
Ternhag A; Giske CG; Hanberger H
Article: PLOS ONE. 2014;9(11):e113539
Klebsiella variicola Is a Frequent Cause of Bloodstream Infection in the Stockholm Area, and Associated with Higher Mortality Compared to K. pneumoniae
Maatallah M; Vading M; Kabir MH; Bakhrouf A; Kalin M; Naucler P; Brisse S; Giske CG
Article: PLOS ONE. 2014;9(7):e103610
Nuclease-Assisted Suppression of Human DNA Background in Sepsis
Song Y; Giske CG; Gille-Johnson P; Emanuelsson O; Lundeberg J; Gyarmati P
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(3):1757-1762
Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments
Tangden T; Hickman RA; Forsberg P; Lagerback P; Giske CG; Cars O
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2014;20(1):34-37
Dissemination of bla_VIM in Greece at the peak of the epidemic of 2005-2006: clonal expansion of Klebsiella pneumoniae clonal complex 147
Hasan CM; Turlej-Rogacka A; Vatopoulos AC; Giakkoupi P; Maatallah M; Giske CG
Article: CURRENT MICROBIOLOGY. 2013;67(6):712-717
Attachment and Biofilm Forming Capabilities of Staphylococcus epidermidis Strains Isolated from Preterm Infants
Hell E; Giske CG; Hultenby K; Danielsson KG; Marchini G
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013;68(9):2074-2077
Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
Schon T; Jureen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2013;32(9):1205-1210
Phenotypic detection of plasmid-acquired AmpC in Escherichia coli-evaluation of screening criteria and performance of two commercial methods for the phenotypic confirmation of AmpC production
Edquist P; Ringman M; Liljequist BO; Wisell KT; Giske CG
Article: LAKARTIDNINGEN. 2013;110(32-33):1398
[ESBL-CARBA can become a problem in Swedish health care].
Giske CG; Kalin M
Article: EUROSURVEILLANCE. 2013;18(28):20525
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.
Glasner C; Albiger B; Buist G; Tambić Andrasević A; Canton R; Carmeli Y; Friedrich AW; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Nordmann P; Poirel L; Rossolini GM; Seifert H; Vatopoulos A; Walsh T; Woodford N; Donker T; Monnet DL; Grundmann H; European Survey on Carbapenemase-Producing Enterob
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2013;41(6):524-526
High prevalence of 16S rRNA methylase RmtB among CTX-M extended-spectrum β-lactamase-producing Klebsiella pneumoniae from Islamabad, Pakistan
Habeeb MA; Haque A; Nematzadeh S; Iversen A; Giske CG
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(4):285-291
Bacteremia in Swedish hematological patients with febrile neutropenia: Bacterial spectrum and antimicrobial resistance patterns
Aust C; Tolfvenstam T; Broliden K; Ljungman P; Kalin M; Giske CG; Ohrmalm L
Article: APMIS. 2013;121(2):146-152
A multiresistant clone of Pseudomonas aeruginosa sequence type 773 spreading in a burn unit in Orumieh, Iran
Yousefi S; Nahaei MR; Farajnia S; Aghazadeh M; Iversen A; Edquist P; Maatallah M; Giske CG
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2013;102(2):182-186
Age and risk factors influence the microbial aetiology of bloodstream infection in children
Luthander J; Bennet R; Giske CG; Nilsson A; Eriksson M
Journal article: EUROSURVEILLANCE. 2013;18(28):9-15
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
Glasner C; Albiger B; Buist G; Tambic Andrasevic A; Canton R; Carmeli Y; Friedrich AW; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Nordmann P; Poirel L; Rossolini GM; Seifert H; Vatopoulos A; Walsh T; Woodford N; Donker T; Monnet DL; Grundmann H
Article: PLOS ONE. 2013;8(10):e76597
High Proportion of Intestinal Colonization with Successful Epidemic Clones of ESBL-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Ecuador
Nordberg V; Peralta AQ; Galindo T; Turlej-Rogacka A; Iversen A; Giske CG; Naver L
Article: APMIS. 2013;121(1):72-78
The relative importance of Staphylococcus saprophyticus as a urinary tract pathogen: distribution of bacteria among urinary samples analysed during 1 year at a major Swedish laboratory
Eriksson A; Giske CG; Ternhag A
Article: PLOS ONE. 2013;8(12):e82069
Four Genotyping Schemes for Phylogenetic Analysis of Pseudomonas aeruginosa: Comparison of Their Congruence with Multi-Locus Sequence Typing
Maatallah M; Bakhrouf A; Habeeb MA; Turlej-Rogacka A; Iversen A; Pourcel C; Sioud O; Giske CG
Journal article: ARCHIVES OF DISEASE IN CHILDHOOD. 2012;97(Suppl 2):a333
1162 Comparative Analysis of Staphylococcus Epidermidis Strains Isolated From Newborns
Hell E; Giske C; Danielsson KG; Marchini G
Journal article: ARCHIVES OF DISEASE IN CHILDHOOD. 2012;97(Suppl 2):a381
1338 High Proportion of Intestinal ESBL Colonization Among Infants at a Neonatal Intensive Care Unit in a Tertiary Hospital in Ecuador
Nordberg V; Quizphe A; Giske C; Iversen A; Galindo T; Ochoa E; Navér L
Article: APMIS. 2012;120(9):724-732
Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL-, AmpC- and carbapenemase-producing Enterobacteriaceae
Hansen F; Hammerum AM; Skov RL; Giske CG; Sundsfjord A; Samuelsen O
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2012;44(9):641-649
Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: Healthcare staff knowledge of and adherence to principles of basic infection prevention
Andersson H; Lindholm C; Iversen A; Giske CG; Ortqvist A; Kalin M; Fossum B
Article: APMIS. 2012;120(8):612-621
First outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting
Rettedal S; Lohr IH; Natas O; Giske CG; Sundsfjord A; Oymar K
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2012;56(5):2735-2738
Diverse Sequence Types of Klebsiella pneumoniae Contribute to the Dissemination of bla_NDM-1 in India, Sweden, and the United Kingdom
Giske CG; Froding I; Hasan CM; Turlej-Rogacka A; Toleman M; Livermore D; Woodford N; Walsh TR
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2012;88(5):422-430
Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study
Kjellander C; Bjorkholm M; Cherif H; Kalin M; Giske CG
Article: MICROBIAL DRUG RESISTANCE. 2012;18(2):189-192
Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
Titelman E; Iversen A; Kalin M; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(3):E37-E45
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
Mouton JW; Brown DFJ; Apfalter P; Canton R; Giske CG; Ivanova M; MacGowan AP; Rodloff A; Soussy C-J; Steinbakk M; Kahlmeter G
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(3):268-281
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
Magiorakos A-P; Srinivasan A; Carey RB; Carmeli Y; Falagas ME; Giske CG; Harbarth S; Hindler JF; Kahlmeter G; Olsson-Liljequist B; Paterson DL; Rice LB; Stelling J; Struelens MJ; Vatopoulos A; Weber JT; Monnet DL
Journal article: DRUG RESISTANCE UPDATES. 2012;15(1-2):1
A rapidly growing number of therapeutics targeting tumor cell-intrinsic and -extrinsic processes is under development for individualized treatment of cancer patients.
Giske CG; Jonkers J
Article: PLOS ONE. 2012;7(12):e51981
Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study
Isendahl J; Turlej-Rogacka A; Manjuba C; Rodrigues A; Giske CG; Naucler P
Article: MICROBIAL DRUG RESISTANCE. 2011;17(4):545-549
A Diversity of OXA-Carbapenemases and Class 1 Integrons Among Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Sweden Belonging to Different International Clonal Lineages
Karah N; Giske CG; Sundsfjord A; Samuelsen O
Article: APMIS. 2011;119(12):853-863
Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
Titelman E; Iversen A; Kahlmeter G; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2011;17(12):1811-1816
Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance
Samuelsen O; Toleman MA; Hasseltvedt V; Fuursted K; Leegaard TM; Walsh TR; Sundsfjord A; Giske CG
Article: CURRENT INFECTIOUS DISEASE REPORTS. 2011;13(5):416-425
When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.
Hanberger H; Giske CG; Giamarellou H
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2011;70(1):137-141
In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14-and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae
Titelman E; Karlsson IM; Ge Y; Giske CG
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2011;17(5):668-674
Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems
Vading M; Samuelsen O; Haldorsen B; Sundsfjord AS; Giske CG
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2011;15(4):502-509
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis
Schon T; Jureen P; Chryssanthou E; Giske CG; Sturegard E; Kahlmeter G; Hoffner S; Angeby KA
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2011;17(4):552-556
A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin
Giske CG; Gezelius L; Samuelsen O; Warner M; Sundsfjord A; Woodford N
Article: PLOS ONE. 2011;6(10):e25617
Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235
Maatallah M; Cheriaa J; Backhrouf A; Iversen A; Grundmann H; Thuy D; Lanotte P; Mastouri M; Elghmati MS; Rojo F; Mejdi S; Giske CG
Article: LAKARTIDNINGEN. 2010;107(48):3040-3043
[More severe bacterial infections could be prevented with vaccine. Rotavirus, influenza and varicella cause thousands of hospital admissions].
Bennet R; Bogdanovic G; Giske CG; Eriksson M
Journal article: BLOOD. 2010;116(21):4868
Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles
Kjellander CK; Cherif H; Björkholm M; Kalin M; Giske CG
Article: EUROSURVEILLANCE. 2010;15(46):22-34
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts
Grundmann H; Livermore DM; Giske CG; Canton R; Rossolini GM; Campos J; Vatopoulos A; Gniadkowski M; Toth A; Pfeifer Y; Jarlier V; Carmeli Y
Article: JOURNAL OF MICROBIOLOGICAL METHODS. 2010;83(2):224-230
The DiversiLab system versus pulsed-field gel electrophoresis: Characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae
Brolund A; Haeggman S; Edquist PJ; Gezelius L; Olsson-Liljequist B; Wisell KT; Giske CG
Article: LAKARTIDNINGEN. 2010;107(40):2392-2395
[Penicillin V and how three dosages became two and than three again. History behind treatment of otitis, sinusitis and pharyngo-tonsillitis].
Giske CG; Eriksson M; Hermansson A; Kumlien J; Odenholt I; Cars O
Article: APMIS. 2010;118(9):713-716
Outbreak of CTX-M-15-producing Klebsiella pneumoniae of sequence type 199 in a Latvian teaching hospital
Dumpis U; Iversen A; Balode A; Saule M; Miklasevics E; Giske CG
Article: JOURNAL OF MICROBIOLOGICAL METHODS. 2010;82(3):229-233
Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae
Brolund A; Wisell KT; Edquist PJ; Elfstrom L; Walder M; Giske CG
Article: THE LANCET INFECTIOUS DISEASES. 2010;10(9):597-602
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kumarasamy KK; Toleman MA; Walsh TR; Bagaria J; Butt F; Balakrishnan R; Chaudhary U; Doumith M; Giske CG; Irfan S; Krishnan P; Kumar AV; Maharjan S; Mushtaq S; Noorie T; Paterson DL; Pearson A; Perry C; Pike R; Rao B; Ray U; Sarma JB; Sharma M; Sheridan E; Thirunarayan MA; Turton J; Upadhyay S; Warner M; Welfare W; Livermore DM; Woodford N
Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2010;16(7):909-911
Transthoracic fine-needle aspiration in the aetiological diagnosis of community-acquired pneumonia
Hernes SS; Hagen E; Tofteland S; Finsen NT; Christensen A; Giske CG; Spindler C; Bakke PS; Bjorvatn B
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2010;65(5):946-952
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
Angeby KA; Jureen P; Giske CG; Chryssanthou E; Sturegard E; Nordvall M; Johansson AG; Werngren J; Kahlmeter G; Hoffner SE; Schon T
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2010;48(5):1853-1858
Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections
Jureen P; Angeby K; Sturegard E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schon T
Article: LAKARTIDNINGEN. 2010;107(11):742
[New guidelines for vancomycin in staphylococcal infections].
Giske CG; Odenholt I; Kahlmeter G
Journal article: DRUG RESISTANCE UPDATES. 2010;13(1-2):1
A message from the New Editor-in-Chief Drug Resistance Updates—The past and the future
Giske CG; Broxterman HJ
Article: LETTERS IN APPLIED MICROBIOLOGY. 2010;50(2):211-215
Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis
Hell E; Giske CG; Nelson A; Romling U; Marchini G
Article: CLINICAL INFECTIOUS DISEASES. 2010;50(2):202-209
Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods
Johansson N; Kalin M; Tiveljung-Lindell A; Giske CG; Hedlund J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2010;54(1):346-352
Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion
Samuelsen O; Toleman MA; Sundsfjord A; Rydberg J; Leegaard TM; Walder M; Lia A; Ranheim TE; Rajendra Y; Hermansen NO; Walsh TR; Giske CG
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(12):5046-5054
Characterization of a New Metallo-β-Lactamase Gene, bla_NDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Yong D; Toleman MA; Giske CG; Cho HS; Sundman K; Lee K; Walsh TR
Article: LAKARTIDNINGEN. 2009;106(47):3160-3161
["The wolf" is already here. Recent data in Stockholm shows increasing antibiotic resistance].
Kronvall G; Giske CG
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(4):786-793
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
Schon T; Jureen P; Giske CG; Chryssanthou E; Sturegard E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(8):3365-3370
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
Kitchel B; Rasheed JK; Patel JB; Srinivasan A; Navon-Venezia S; Carmeli Y; Brolund A; Giske CG
Article: PEDIATRIC RESEARCH. 2009;66(2):174-178
Staphylococcus epidermidis Isolated From Newborn Infants Express Pilus-Like Structures and Are Inhibited by the Cathelicidin-Derived Antimicrobial Peptide LL37
Nelson A; Hultenby K; Hell E; Riedel HM; Brismar H; Flock J-I; Lundahl J; Giske CG; Marchini G
Article: MICROBIAL DRUG RESISTANCE. 2009;15(2):91-95
Interplay of Efflux, Impermeability, and AmpC Activity Contributes to Cefuroxime Resistance in Clinical, Non-ESBL-Producing Isolates of Escherichia coli
Kallman O; Giske CG; Samuelsen O; Wretlind B; Kalin M; Olsson-Liljequist B
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;63(4):654-658
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden
Samuelsen O; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
Journal article: LAKARTIDNINGEN. 2009;106(5):291-292
[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime].
Hanberger H; Odenholt I; Giske CG; Kahlmeter G
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;63(1):1-4
Redefining extended-spectrum β-lactamases: balancing science and clinical need
Giske CG; Sundsfjord AS; Kahlmeter G; Woodford N; Nordmann P; Paterson DL; Canton R; Walsh TR
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;62(5):986-990
Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels
Kaellman O; Motakefi A; Wretlind B; Kalin M; Olsson-Liljequist B; Giske CG
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2008;46(5):1878-1880
Identification of the first VIM metallo-β-lactamase-producing multiresistant Aeromonas hydrophila strain
Libisch B; Giske CG; Kovacs B; Toth TG; Fuezi M
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;61(4):827-830
Evaluation of phenotypic tests for the detection of metallo-β-lactamase-producing Pseudomonas aeruginosa in a low prevalence country
Samuelsen O; Buaro L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
Article: MICROBIAL DRUG RESISTANCE. 2008;14(1):23-30
Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa
Giske CG; Buaro L; Sundsfjord A; Wretlind B
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2008;40(6-7):487-494
Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs
Erlandsson M; Gill H; Nordlinder D; Giske CG; Jonas D; Nilsson LE; Walther S; Hanberger H
Article: LAKARTIDNINGEN. 2007;104(24-25):1906-1910
[Invasive pneumococcal infection can cause meningitis in children. Uncertainty about the mass protective effect of the vaccine from USA].
Eriksson M; Bennet R; Fuhrmann D; Giske CG; Rylander M
Journal article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007;29:s90-s91
O432 Polyclonal distribution of extended-spectrumβlactamase-producing Escherichia coli and Klebsiella pneumoniae in Stockholm
Titelman E; Iversen A; Lagergren Å; Kühn I; Kahlmeter G; Giske C
Journal article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007;29:s225
P871 Phenotypic detection of AmpC in E. coli: comparison of cloxacillin, boronic acid and EDTA disk synergy assays
Giske C; Haldorsen B; Lundblad E; Aasnæs B; Simonsen G; Sundsfjord A
Journal article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007;29:s223-s224
P867 Carbapenem resistance mechanisms in Norwegian clinical isolates of Pseudomonas aeruginosa
Samuelsen Ø; Buarø L; Aasnæs B; Giske CG; Haldorsen B; Simonsen GS; Leegaard TM; Sundsfjord A
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2006;44(12):4309-4315
Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing
Giske CG; Libisch B; Colinon C; Scoulica E; Pagani L; Fuzi M; Kronvall G; Rossolini GM
Article: LAKARTIDNINGEN. 2006;103(35):2478-2481
[Nosocomial infections with multiresistant bacteria--not only staphylococci].
Petersson J; Giske CG; Aufwerber E; Jörbeck H
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2006;55(3):169-178
Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR
Kais M; Spindler C; Kalin M; Ortqvist A; Giske CG
Article: LAKARTIDNINGEN. 2006;103(14):1121-1122
[Quinolones should not be administered in monotherapy for Pseudomonas aeruginosa infection].
Giske CG; Wretlind B
Article: APMIS. 2005;113(3):187-196
Carbapenem resistance mechanisms in Pseudomonas aeruginosa:: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
Show more

All other publications

Review: CLINICAL INFECTIOUS DISEASES. 2024;79(2):516-523
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute
Narayanan N; Mathers AJ; Wenzler E; Moore NM; Giske CG; Mendes RE; Edelstein PH
Preprint: BIORXIV. 2024
GPT-4 based AI agents – the new expert system for detection of antimicrobial resistance mechanisms?
Giske CG; Bressan M; Fiechter F; Hinic V; Mancini S; Nolte O; Egli A
Letter: CLINICAL INFECTIOUS DISEASES. 2024;:ciae246
Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute
Narayanan N; Mathers AJ; Wenzler E; Moore NM; Giske CG; Mendes RE; Edelstein PH
Review: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2023;12(3):211-225
The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review
Andersson V; Froberg G; Dahl V; Chryssanthou E; Giske C; Schon T; Forsman L
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(9):1179-1181
The clinical impact of errors in semiautomated antimicrobial susceptibility testing of multidrug-resistant Enterobacterales causing bloodstream infections
Sundsfjord A; Giske C
Preprint: BIORXIV. 2022
Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
Mikaeloff F; Gelpi M; Benfeitas R; Knudsen AD; Vestad B; Høgh J; Hov JR; Benfield T; Murray D; Giske CG; Mardinoglu A; Trøseid M; Nielsen SD; Neogi U
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(6):764-767
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing Comment
Gatermann S; Das S; Dubreuil L; Giske CG; Kahlmeter G; Lina G; Lindemann C; MacGowan A; Meletiadis J; Rossolini GM; Turnidge J; Canton R
Letter: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2022;41(4):e182-e185
Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One
Aguilera-Alonso D; Canton R; Giske CG; Kahlmeter G; Kohns Vasconcelos M; Papan C; Turnidge J
Letter: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2022;28(4):625-627
Searching high and low: call for a joint ESPID-EUCAST survey on dosage of antibacterial agents in children-part one
Aguilera-Alonso D; Canton R; Giske CG; Kahlmeter G; Vasconcelos MK; Papan C; Turnidge J
Review: JOURNAL OF CLINICAL MICROBIOLOGY. 2022;60(3):e0027621-e00221
Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
Giske CG; Turnidge J; Canton R; Kahlmeter G
Review: CURRENT OPINION IN INFECTIOUS DISEASES. 2021;34(6):599-610
New evidence for managing Gram-negative bloodstream infections
Nutman A; Tellapragada C; Giske CG; Yahav D
Corrigendum: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES. 2021;40(12):2487-2488
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients (vol 4, pg 1, 2021)
Tellapragada C; Giske CG
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021;76(7):1949-1950
Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study
Giske CG; Kahlmeter G; MacGowan A; Turnidge J
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2021;57(5):106344
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli
Scudeller L; Righi E; Chiamenti M; Bragantini D; Menchinelli G; Cattaneo P; Giske CG; Lodise T; Sanguinetti M; Piddock LJV; Franceschi F; Ellis S; Carrara E; Savoldi A; Tacconelli E
Letter: THE LANCET INFECTIOUS DISEASES. 2021;21(5):e117
Beyond COVID-19-a paradigm shift in infection management?
Vehreschild MJGT; Tacconelli E; Giske CG; Peschel A
Corrigendum: CLINICAL MICROBIOLOGY REVIEWS. 2021;34(2):e00021
New β-Lactam-β-Lactamase Inhibitor Combinations (vol 34, e00115-20, 2021)
Yahav D; Giske CG; Gramatniece A; Abodakpi H; Tam VH; Leibovici L
Review: CLINICAL MICROBIOLOGY REVIEWS. 2020;34(1):e00115-e00120
New β-Lactam-β-Lactamase Inhibitor Combinations.
Yahav D; Giske CG; Grāmatniece A; Abodakpi H; Tam VH; Leibovici L
Letter: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(12):1692-1693
Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility.
Kahlmeter G; Cantón R; Giske CG; Turnidge J; EUCAST Steering Committee
Preprint: MEDRXIV. 2020
The Unyvero Hospital-Acquired pneumonia panel for diagnosis of secondary bacterial pneumonia in COVID-19 patients
Tellapragada C; Giske CG
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(11):1453-1455
What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?
Schon T; Koser CU; Werngren J; Viveiros M; Georghiou S; Kahlmeter G; Giske C; Maurer F; Lina G; Turnidge J; van Ingen J; Jankovic M; Goletti D; Maria Cirillo D; Santin M; Cambau E
Other: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2020;26(1):125-126
Obituary: Johan Willem Mouton
Kluytmans J; Voss A; Kahlmeter G; Giske C; MacGowan A; Brown D; Gatermann S; Lina G; Lindemann C; Turnidge J; Canton R; Petinaki E; Vaz CP; Rodriguez Bano J
Letter: JOURNAL OF CLINICAL MICROBIOLOGY. 2019;58(1):e01519
Reply from Kahlmeter and Giske to Brecher, 'EUCAST and CLSI Point-Counterpoint on Susceptibility Breakpoints: Do Two "I Agree"s Miss the Point?'
Kahlmeter G; Giske CG
Review: JOURNAL OF CLINICAL MICROBIOLOGY. 2019;57(9):e01129-e01119
Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility Results
Kahlmeter G; Giske CG; Kirn TJ; Sharp SE
Conference publication: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75:S12
Interindividual variability in plasma levels of beta-lactam antibiotics in critically ill patients with or without continuous renal replacement therapy
Eliasson E; Giske C; Petersson J
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2019;25(1):13-19
ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus
Dyar OJ; Beovic B; Pulcini C; Tacconelli E; Hulscher M; Cookson B
Letter: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2018;24(12):1345
A plea from EUCAST for standardization of disc susceptibility testing antimicrobial codes
Turnidge J; Lina G; Giske C
Other: LAKARTIDNINGEN. 2018;115:FCX7
[Psittacosis - a forgotten diagnosis in Sweden?].
Marking U; Hammas B; Grabbe M; Giske C
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2018;73(9):2585-2586
MIC-based dose adjustment: facts and fables-authors' response
Mouton JW; Muller AE; Canton R; Giske CG; Kahlmeter G; Turnidge J
Editorial comment: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2018;24(2):93-94
Colistin antimicrobial susceptibility testing-can the slow and challenging be replaced by the rapid and convenient?
Giske CG; Kahlmeter G
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2017;23(1):2-22
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
Ellington MJ; Ekelund O; Aarestrup FM; Canton R; Doumith M; Giske C; Grundman H; Hasman H; Holden MTG; Hopkins KL; Iredell J; Kahlmeter G; Koser CU; MacGowan A; Mevius D; Mulvey M; Naas T; Peto T; Rolain J-M; Samuelsen O; Woodford N
Review: FEMS MICROBIOLOGY REVIEWS. 2016;40(4):437-463
Escherichia coli: an old friend with new tidings
Vila J; Saez-Lopez E; Johnson JR; Romling U; Dobrindt U; Canton R; Giske CG; Naas T; Carattoli A; Martinez-Medina M; Bosch J; Retamar P; Rodriguez-Bano J; Baquero F; Soto SM
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2015;21(10):899-905
Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin
Giske CG
Review: DRUG RESISTANCE UPDATES. 2015;20:29-38
Carbapenemase-producing Enterobacteriaceae in Sweden 2007-2013: Experiences from seven years of systematic surveillance and mandatory reporting
Lofmark S; Sjostrom K; Makitalo B; Edquist P; Wisell KT; Giske CG
Review: JOURNAL OF INTERNAL MEDICINE. 2015;277(5):501-512
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
Tangden T; Giske CG
Review: LAKARTIDNINGEN. 2015;112:CW3P
[Beta lactam antibiotics and the question of dose regimen for severe infection. Prolonged infusion theoretically appealing--yet no evidence of clinical benefit].
Leander G; Eliasson E; Hanberger H; Giske C
Review: UPSALA JOURNAL OF MEDICAL SCIENCES. 2014;119(2):154-161
Antibiotic consumption and antibiotic stewardship in Swedish hospitals
Hanberger H; Skoog G; Ternhag A; Giske CG
Conference publication: INTENSIVE CARE MEDICINE. 2014;40:S240-S241
MEROPENEM AND PIPERACILLIN CONCENTRATIONS IN ICU PATIENTS TREATED WITH CONTINUOUS RENAL REPLACEMENT THERAPY
Petersson J; Giske CG; Eliasson E
Conference publication: HAEMATOLOGICA. 2014;99:63
BLOOD STREAM INFECTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: STABLE DISTRIBUTION BUT WITH INCREASED MORTALITY RATE?
Kjellander C; Bjorkholm M; Landgren O; Kallman O; Weibull CE; Love TJ; Giske CC; Kristinsson SY
Letter: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(8):655-656
Rational use of aminoglycosides - author response
Hanberger H; Fredriksson M; Ternhag A; Giske CG
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(3):161-175
Rational use of aminoglycosides-Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA)
Hanberger H; Edlund C; Furebring M; Giske CG; Melhus A; Nilsson LE; Petersson J; Sjolin J; Ternhag A; Werner M; Eliasson E
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2013;19(2):141-160
EUCAST expert rules in antimicrobial susceptibility testing
Leclercq R; Canton R; Brown DFJ; Giske CG; Heisig P; MacGowan AP; Mouton JW; Nordmann P; Rodloff AC; Rossolini GM; Soussy C-J; Steinbakk M; Winstanley TG; Kahlmeter G
Conference publication: INTENSIVE CARE MEDICINE. 2013;39:S220
STANDARD DOSING REGIMENS OF PIPERACILLIN AND MEROPENEM FAIL TO ACHIEVE ADEQUATE SERUM CONCENTRATIONS IN ICU PATIENTS
Petersson J; Giske CG; Eliasson E
Conference publication: EUROPEAN RESPIRATORY JOURNAL. 2013;42
Relevance of respiratory infections in preschool wheeze - A hospital based study
Hammar KS; Hedlin G; Konradsen JR; Nordlund RB; Kull RI; Giske CG; Pedroletti C; Soderhall C; Melen E
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(5):432-438
Identification and screening of carbapenemase-producing Enterobacteriaceae
Nordmann P; Gniadkowski M; Giske CG; Poirel L; Woodford N; Miriagou V
Review: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2012;18(5):413-431
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Canton R; Akova M; Carmeli Y; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Miriagou V; Naas T; Rossolini GM; Samuelsen O; Seifert H; Woodford N; Nordmann P
Corrigendum: JOURNAL OF MICROBIOLOGICAL METHODS. 2012;88(1):188
Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae (vol 82, pg 229, 2010)
Brolund A; Wisell KT; Edquist PJ; Elfstrom L; Walder M; Giske CG
Meeting abstract: PEDIATRIC RESEARCH. 2011;70:457
LONG-TERM FOLLOW-UP AFTER NEONATAL COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE GRAM-NEGATIVE BACTERIA
Kock K; Jonsson B; Aspevall O; Iversen A; Giske CG; Nordberg V; Norman M; Naver L
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2011;38(4):281-290
Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion
Kronvall G; Giske CG; Kahlmeter G
Letter: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2011;55(9):4492-4493
Wild-Type MIC Distributions Must Be Considered To Set Clinically Meaningful Susceptibility Testing Breakpoints for All Bacterial Pathogens, Including Mycobacterium tuberculosis
Angeby K; Giske CG; Jureen P; Schon T
Review: DRUG RESISTANCE UPDATES. 2011;14(4-5):236-250
Epidemiology and characteristics of antimicrobial resistance in China
Xiao Y-H; Giske CG; Wei Z-Q; Shen P; Heddini A; Li L-J
Meeting abstract: PEDIATRIC RESEARCH. 2010;68:693
LONG-TERM FOLLOW-UP AFTER NEONATAL COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE GRAM-NEGATIVE BACTERIA
Kokk K; Jonsson B; Aspevall O; Iversen A; Giske CG; Norman M; Naver L
Review: DRUG RESISTANCE UPDATES. 2010;13(4-5):93-98
Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future
Giske CG; Cornaglia G
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2010;14:E179
Detecting Carbapenemase Producers in the Clinic
Giske C
Published conference paper: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2010;16(2):112-122
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
Miriagou V; Cornaglia G; Edelstein M; Galani I; Giske CG; Gniadkowski M; Malamou-Lada E; Martinez-Martinez L; Navarro F; Nordmann P; Peixe L; Pournaras S; Rossolini GM; Tsakris A; Vatopoulos A; Canton R
Review: LAKARTIDNINGEN. 2009;106(34):2052-2056
[Quantitative lower respiratory tract cultures and how to interpret them. Infection must be discriminated from colonization].
Petersson J; Kalin M; Giske CG
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(2):430-431
Activity of cephalosporin CXA-101 (FR264205) and comparators against extended-spectrum-β-lactamase-producing Pseudomonas aeruginosa
Giske CG; Ge J; Nordmann P
Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(1):213-215
Redefining extended-spectrum β-lactamases: balancing science and clinical need-authors' response
Giske CG; Sundsfjord AS; Kahlmeter G; Woodford N; Nordmann P; Paterson DL; Canton R; Walsh TR
Letter: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(1):331-332
The First Metallo-β-Lactamase Identified in Norway Is Associated with a TniC-Like Transposon in a Pseudomonas aeruginosa Isolate of Sequence Type 233 Imported from Ghana
Samuelsen O; Buaro L; Toleman MA; Giske CG; Hermansen NO; Walsh TR; Sundsfjord A
Review: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;62(1):35-40
Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue
Wisell KT; Kahlmeter G; Giske CG
Review: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2008;52(3):813-821
Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Giske CG; Monnet DL; Cars O; Carmeli Y
Published conference paper: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2008;60(3):255-261
Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia
Johansson N; Kalin M; Giske CG; Hedlund J
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;68(2):246-247
Staphylococcus epidermidis isolated from newborn infants express pilus structures
Nelson A; Hultenby K; Riedel H; Giske C; Motakefi A; Marchini G
Thesis / dissertation: 2007
Carbapenem resistance in Pseudomonas aeruginosa
Giske, Christian
Published conference paper: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2005;11(8):662-669
Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA
Giske CG; Borén C; Wretlind B; Kronvall G
Letter: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2003;47(9):3034-3035
VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden
Giske CG; Rylander M; Kronvall G
Show more

Grants

Improving surveillance of antibiotic-resistant Pseudomonas aeruginosa in Europe
Swedish Research Council
1 January 2023 - 31 December 2023
IDAR-Neo - Identification and characterization of fecal carriage of antimicrobial resistant bacteria in neonates in low-resource settings
Swedish Research Council
1 January 2023 - 31 December 2025
Pivmecillinam in the treatment of urinary tract infections caused by ESBL-producing bacteria - a randomized study
Swedish Research Council
1 January 2022 - 31 December 2023
Bridging the knowledge gap in adaptive drug resistance and fitness properties of Gram-negative bacteria
Swedish Research Council
1 December 2020 - 31 December 2022
Identification of bacterial infections and antibiotic resistance in low income countries by rapid optical DNA mapping
Swedish Research Council
1 January 2020 - 31 December 2022
Microbial and host responses in the respiratory tract of covid-19 patients as a basis for optimal treatment
Swedish Heart-Lung Foundation
1 January 2020 - 31 December 2020
Individualiserad behandling av multiresistent tuberkulos genom användning av nya diagnostiska och farmakologiska strategier samt nya läkemedelsgrupper
Swedish Heart-Lung Foundation
1 January 2020 - 31 December 2022
Carbapenem resistance in Bacteroides fragilis
Southern and Eastern Norway Regional Health Authority
1 January 2019
Plasmid Identification and Detection in South-East Asia - Enterobacteriaceae resistant to last resort Carbapenems and Colistin
Swedish Research Council
1 April 2018 - 31 December 2020
Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens (PILGRIM)
Swedish Research Council
1 December 2017 - 31 December 2019
Selection and development of a therapeutic antibody against drug-resistant Klebsiella pneumoniae
VINNOVA
1 November 2017 - 1 November 2020
Portable diagnostics for disease and drug resistance with focus on malaria and bacterial infections
Swedish Research Council
1 January 2017 - 31 December 2019
Exploring the role of prophages and the CRISPR/Cas system in successful clones of extensively drug resistant Klebsiella pneumoniae
Swedish Research Council
1 January 2017 - 31 December 2019
Multi-resistant Klebsiella pneumoniae in newborns.
Western Norway Regional Health Authority
1 January 2011 - 31 December 2014

Employments

Professor/Senior Physician, Department of Laboratory Medicine, Karolinska Institutet, 2018-

Degrees and Education

Docent, Karolinska Institutet, 2010
Doctor Of Philosophy, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2007

About me

Selected publications

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI